Longevity Venture Fund I, LLC

Location: Cave Creek, AZ

LVF I is a $20M venture fund building a vertically integrated longevity platform spanning personalized cellular regeneration (Cellarion), xenotransplantation (CrofaBiotech), and direct-to-patient clinical delivery (RENUE Medical Centre). The fund de-risks the historically binary biotech model by blending cash-flow generating businesses — Cellarion's iPSC biobank and RENUE's regenerative medicine clinic — with high-upside scientific platforms, providing investors current income alongside transformative upside in a single vehicle. Current Portfolio Companies Cellarion - Seed Cellarion is a dual-business iPSC therapeutics company that generates near-term cash flow from personalized bio cell banking ($65K per client) while running 5 clinical trials across billion-dollar indications — for a total investment of just $4.7M. Competitors targeting the same science have raised $600M–$950M. The biobank funds operations from Day 1 while clinical programs target transformational exit outcomes in regenerative medicine. CrofaBiotech - Seed CrofaBiotech is solving the global organ shortage crisis through precision CRISPR/Cas9 gene editing and xenotransplantation. The proprietary CrofaPig® line carries 10 targeted genetic modifications that reduce immune rejection by 80%. With 4M+ patients needing transplants annually and fewer than 5% receiving one, CrofaBiotech reaches its first human clinical trial in April 2026 for just $2.7M — while competitors have raised $500M–$950M+ to reach the same milestone. Renue Medical Center - Growth RENUE is a premium regenerative medicine clinic in Nuevo Vallarta, Mexico, with a second facility planned for Tijuana to capture Southern California medical tourism demand. RENUE will be one of 1–2 facilities in the world treating patients with iPSCs — and the only facility globally with an iPSC production laboratory onsite the treatment centre. This co-location eliminates supply chain risk, reduces turnaround time, and creates a vertically integrated cell therapy platform that no competitor can replicate at this price point. Data Room Link: